Search

In recent years, following the introduction of new therapies, the life expectancy of patients with cystic fibrosis has increased significantly, exceeding the 50-year age threshold. This has also resulted in a change in demographics so that today, nearly 60 percent of patients with cystic fibrosis are adults. Thus, the adult population is burdened not only with the clinical features characteristic of the disease but also with the pathological conditions typical of aging (from hypertension to heart disease). This change in cystic fibrosis highlights the importance of a transition process from pediatric to adult medicine, in the same way as with other chronic diseases. Therefore, the objective of this review article will be to focus on the peculiarities of the transitional population and the creation of a transitional care model. [ABSTRACT FROM AUTHOR]